In hepatocellular carcinoma (HCC), elevated HMGB1 released from gluconeogenic enzyme fructose 1,6-bisphosphatase (FBP1)-deficient hepatocytes triggers HSCs activation. Here, HMGB1 is linked to hepatocellular carcinoma.